Exploration of Therapeutic Targets Using CDK4 Inhibitors for Head and Neck Mucosal Melanoma
Abemaciclib and palbociclib may suppress MM cell proliferation. The CDK4 signaling pathway is a potential target for molecular-targeted therapies in MM.
Authors
- Akira Ishikawa (ORCID: https://orcid.org/0000-0001-7104-1342)
- Hiroaki Tahara
- Takashi Ishino
- Takao Hamamoto
- Makiko Fujii
- Sachio Takeno (ORCID: https://orcid.org/0000-0002-9853-2501)
- Nobuyuki Chikuie
- Takayoshi Hattori
- Bingwen Xu
- Yuichi Mine (ORCID: https://orcid.org/0000-0002-7057-1955)
- Minoru Hattori (ORCID: https://orcid.org/0000-0002-7478-0033)
- Tsutomu Ueda
- Yuki Sato
- Takayuki Taruya
- Tomoya Suehiro
Institutions
- Hiroshima University (JP)
Publication Details
- Journal
- Otolaryngology
- Published
- 2026-01-22
- DOI
- https://doi.org/10.1002/ohn.70137
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00